These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33185132)

  • 41. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.
    Bayomi MA; Abanumay KA; Al-Angary AA
    Int J Pharm; 2002 Aug; 243(1-2):107-17. PubMed ID: 12176299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
    AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced Solubility of Albendazole in Cyclodextrin Inclusion Complex: A Molecular Modeling Approach and Physicochemical Evaluation.
    de Melo CG; da Costa LAG; Rabello MM; de Albuquerque Wanderley Sales V; Ferreira AS; da Silva PCD; Nishimura RHV; da Silva RMF; de Araújo Rolim L; Neto PJR
    Curr Drug Deliv; 2022; 19(1):86-92. PubMed ID: 34126897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fabrication of sulfobutylether-β-cyclodextrin/glabridin inclusion complex for promoting bioactivities.
    Wang W; Tang K; Huang C; Liu A
    Arch Pharm (Weinheim); 2024 Aug; 357(8):e2400082. PubMed ID: 38724255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
    Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
    Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
    Ruz V; Froeyen M; Busson R; González MM; Baudemprez L; Van den Mooter G
    Int J Pharm; 2012 Dec; 439(1-2):275-85. PubMed ID: 22989977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physicochemical characterization and in vitro dissolution behaviour of celecoxib-beta-cyclodextrin inclusion complexes.
    Sinha VR; Anitha R; Ghosh S; Amita ; Kumria R; Bhinge JR; Kumar M
    Acta Pharm; 2007 Mar; 57(1):47-60. PubMed ID: 19839406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inclusion complexation of nimesulide with beta-cyclodextrins.
    Vavia PR; Adhage NA
    Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and
    Al-Heibshy FNS; Başaran E; Öztürk N; Demirel M
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1495-1506. PubMed ID: 32804005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies.
    Reddy MN; Rehana T; Ramakrishna S; Chowdhary KP; Diwan PV
    AAPS PharmSci; 2004 Mar; 6(1):E7. PubMed ID: 15198508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO; Omoruyi SI; Oladimeji FA
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation, characterization and biological evaluation of β-cyclodextrin-biotin conjugate based podophyllotoxin complex.
    Zhao X; Qiu N; Ma Y; Liu J; An L; Zhang T; Li Z; Han X; Chen L
    Eur J Pharm Sci; 2021 May; 160():105745. PubMed ID: 33549707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
    Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
    Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analytical techniques to recognize inclusion complexes formation involving monoterpenes and cyclodextrins: A study case with (-) borneol, a food ingredient.
    Santana DVS; Trindade IAS; Carvalho YMBG; Carvalho-Neto AG; Silva ECD; Silva-Júnior EF; Leite RFS; Quintans-Júnior LJ; Aquino TM; Serafini MR; Guterres SS; Scotti L; Scotti MT; Araújo AAS; Frank LA; Menezes PP
    Food Chem; 2021 Mar; 339():127791. PubMed ID: 32860997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
    Sherje A; Londhe V
    Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of the hydrophobic nature of triacetyl-beta-cyclodextrin on the complexation with nicardipine hydrochloride: physicochemical and dissolution properties of the kneaded and spray-dried complexes.
    Fernandes CM; Veiga FJ
    Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1597-602. PubMed ID: 12499598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Solving the Delivery Problems of Triclabendazole Using Cyclodextrins.
    Real D; Leonardi D; Williams RO; Repka MA; Salomon CJ
    AAPS PharmSciTech; 2018 Jul; 19(5):2311-2321. PubMed ID: 29845501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
    Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W
    J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preformulative assessment of preformed complexes of gemfibrozil, with cyclodextrins.
    Ain S; Philip B; Pathak K
    PDA J Pharm Sci Technol; 2008; 62(4):300-8. PubMed ID: 19174958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.